<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="embj2020106057-fig-0001" orientation="portrait" position="float">
 <label>Figure 1</label>
 <caption>
  <title>
   <italic>Cholesterol 25‐hydroxylase (
    <styled-content style="fixed-case" toggle="no">CH</styled-content>25H)
   </italic> is induced by 
   <styled-content style="fixed-case" toggle="no">SARS</styled-content>‐CoV‐2 and restricts viral infection
  </title>
  <p>
   <list list-type="simple" id="embj2020106057-list-0002">
    <list-item>
     <label>A</label>
     <p>IFNs and ISGs were induced by SARS‐CoV-2 infection in lung epithelial cell lines: Calu‐3 and A549‐ACE2 were infected with SARS‐CoV-2 at MOI = 2 for 24 h; A549 was challenged with IAV at MOI = 5 for 9 h; A549 was infected with HPIV3 and RSV at MOI = 2 for 24 h (Blanco‐Melo 
      <italic>et al</italic>, 
      <xref rid="embj2020106057-bib-0003" ref-type="ref">2020</xref>). Color key represents log2(fold change) relative to uninfected control cells. 
      <italic>CH25H</italic> was highlighted by red asterisk.
     </p>
    </list-item>
    <list-item>
     <label>B</label>
     <p>Expression of 
      <italic>CH25H</italic> in heathy donors and COVID‐19-infected patients. The box plot shows the expression of 
      <italic>CH25H</italic> in macrophages of bronchoalveolar lavage fluids from four healthy donors, three moderate COVID‐19-infected patients and six severe COVID‐19-infected patients by scRNA‐seq analysis (Liao 
      <italic>et al</italic>, 
      <xref rid="embj2020106057-bib-0018" ref-type="ref">2020</xref>). *
      <italic>P</italic> &lt; 0.05, ****
      <italic>P</italic> &lt; 0.0001, by Student's 
      <italic>t</italic>‐test.
     </p>
    </list-item>
    <list-item>
     <label>C–E</label>
     <p>Characterization of SARS‐CoV-2 pseudovirus. (C) SARS‐CoV-2, SARS‐CoV, and VSV pseudovirus (VSV‐G) were concentrated by ultracentrifuge. Incorporation of spike protein on viral membrane was analyzed by Western blot using an antibody recognizing S2 subunit of SARS‐CoV and SARS‐CoV-2. VSV Matrix protein served as a loading control for viral particles. Black arrows indicate full length S and cleaved spike (S2 subunit), respectively. (D) SARS‐CoV-2 pseudovirus infection in Calu‐3 cells with or without treatment of coronavirus fusion peptide EK1. Luciferase activity was measured to quantify the infection. (E) SARS‐CoV-2 pseudovirus infection in Calu‐3 cells transduced with non‐targeting control or ACE2‐specific sgRNA. Luciferase activity was measured to quantify the infection. Mean ± SD of 
      <italic>n</italic> = 3. ***
      <italic>P &lt; </italic>0.001, ****
      <italic>P &lt; </italic>0.0001, by Student's 
      <italic>t</italic>‐test.
     </p>
    </list-item>
    <list-item>
     <label>F, G</label>
     <p>Overexpression of 
      <italic>CH25H</italic> restricts SARS‐CoV-2 entry. Calu‐3 cells transduced with lentivirus overexpressing 
      <italic>CH25H</italic> or empty vector were infected with SARS‐CoV-2 pseudovirus encoding Fluc or EGFP and pseudovirus infection was quantified by luciferase assay (F) or visualized by fluorescence microscopy (G). Scale bar, 100 μm. Mean ± SD of 
      <italic>n</italic> = 3. ****
      <italic>P</italic> &lt; 0.0001, by Student's 
      <italic>t</italic>‐test.
     </p>
    </list-item>
   </list>
  </p>
  <p>
   <named-content content-type="attribution">Source data are available online for this figure.</named-content>
  </p>
 </caption>
 <graphic id="nlm-graphic-5" xlink:href="EMBJ-9999-e106057-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
